Flex Pharma Reports Second Quarter 2015 Financial Results

Go back to Flex Pharma Reports Second Quarter 2015 Financial Results

Flex Pharma (FLKS) Misses Q2 EPS by 10c

August 5, 2015 7:57 AM EDT

Flex Pharma (NASDAQ: FLKS) reported Q2 EPS of ($0.47), $0.10 worse than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Flex Pharma (FLKS) click here.

... More